CR9431A - Hidroxamatos como inhibidores de la histona deacetilasa y formulaciones farmaceuticas que los contienen - Google Patents
Hidroxamatos como inhibidores de la histona deacetilasa y formulaciones farmaceuticas que los contienenInfo
- Publication number
- CR9431A CR9431A CR9431A CR9431A CR9431A CR 9431 A CR9431 A CR 9431A CR 9431 A CR9431 A CR 9431A CR 9431 A CR9431 A CR 9431A CR 9431 A CR9431 A CR 9431A
- Authority
- CR
- Costa Rica
- Prior art keywords
- hydroxamates
- inhibitors
- pharmaceutical formulations
- formulations containing
- histone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/11—Compounds covalently bound to a solid support
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Se describen compuestos de estructura (I) que tienen actividad inhibidora de histona deacetilasa (HDCA). Los compuestos estan quimicamente caracterizados por la presencia de acido hidroxamico, con zinc como agente quelante, y un nucleo aromatico conectado a traves de un enlazador en donde esta presente ya sea un sistema aromatico biciclico o un anillo piperidino.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000041A ITFI20050041A1 (it) | 2005-03-15 | 2005-03-15 | Idrossammati come inibitori dell'istone deacelitasi, loro preparazione e formulazioni farmaceutiche che li contengono |
IT000239A ITFI20050239A1 (it) | 2005-03-15 | 2005-11-21 | Idrossammati come inibitori dell'istone deacetilasi e formulazioni farmaceutiche che li contegono |
Publications (1)
Publication Number | Publication Date |
---|---|
CR9431A true CR9431A (es) | 2008-07-31 |
Family
ID=36617217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR9431A CR9431A (es) | 2005-03-15 | 2007-10-11 | Hidroxamatos como inhibidores de la histona deacetilasa y formulaciones farmaceuticas que los contienen |
Country Status (22)
Country | Link |
---|---|
US (1) | US20080207694A1 (es) |
EP (1) | EP1868997A1 (es) |
JP (1) | JP2008533091A (es) |
KR (1) | KR20070112240A (es) |
CN (1) | CN101155780A (es) |
AP (1) | AP2007004188A0 (es) |
AR (1) | AR058002A1 (es) |
AU (1) | AU2006224624A1 (es) |
BR (1) | BRPI0606290A2 (es) |
CA (1) | CA2600528A1 (es) |
CO (1) | CO6321134A2 (es) |
CR (1) | CR9431A (es) |
EA (1) | EA012909B1 (es) |
IL (1) | IL185882A0 (es) |
IT (2) | ITFI20050041A1 (es) |
MA (1) | MA29389B1 (es) |
MX (1) | MX2007011072A (es) |
NO (1) | NO20075281L (es) |
SA (1) | SA06270135B1 (es) |
TW (1) | TW200724529A (es) |
WO (1) | WO2006097460A1 (es) |
ZA (1) | ZA200708749B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007038459A2 (en) * | 2005-09-27 | 2007-04-05 | Novartis Ag | Carboxyamine compounds and their use in the treatment of hdac dependent diseases |
GB0523040D0 (en) * | 2005-11-11 | 2005-12-21 | Cyclacel Ltd | Combination |
WO2009026446A2 (en) * | 2007-08-21 | 2009-02-26 | Arqule, Inc. | Hdac inhibitors |
CN102775368B (zh) | 2011-05-10 | 2016-08-17 | 上海驺虞医药科技有限公司 | 一类噻唑类化合物及其制备方法和用途 |
WO2017108282A1 (en) * | 2015-12-22 | 2017-06-29 | Kancera Ab | Bicyclic hydroxamic acids useful as inhibitors of mammalian histone deacetylase activity |
PT3398598T (pt) * | 2015-12-31 | 2022-07-12 | Hitgen Ltd | Derivado de sulfonamida e método de preparação e utilização do mesmo |
WO2019157020A1 (en) | 2018-02-06 | 2019-08-15 | The Board Of Trustees Of The University Of Illinois | Substituted benzothiophene analogs as selective estrogen receptor degraders |
CN112325620B (zh) * | 2020-11-13 | 2022-04-19 | 南阳中联水泥有限公司 | 一种水泥生产高效烘干设备 |
CN112516142B (zh) * | 2020-12-11 | 2021-10-15 | 北京华氏精恒医药科技有限公司 | 一种具有hdac抑制活性的药物组合物、制备方法及其用途 |
WO2023003468A1 (en) * | 2021-07-23 | 2023-01-26 | Rijksuniversiteit Groningen | Novel inhibitors of histone deacetylase (hdac), and methods, compositions and uses related thereto. |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003218735B2 (en) * | 2002-03-13 | 2009-03-12 | Janssen Pharmaceutica N.V. | Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
CA2479906C (en) * | 2002-04-03 | 2011-02-08 | Topotarget Uk Limited | Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
US20040072802A1 (en) * | 2002-10-09 | 2004-04-15 | Jingwu Duan | Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha |
US7723376B2 (en) * | 2003-07-15 | 2010-05-25 | Korea Research Institute Of Bioscience And Biotechnology | 2-oxo-heterocyclic compounds and pharmaceutical compositions |
AR046920A1 (es) * | 2003-10-27 | 2006-01-04 | S Bio Pte Ltd | Hidroxamatos conectados a acilurea y conectado a sulfonilurea |
-
2005
- 2005-03-15 IT IT000041A patent/ITFI20050041A1/it unknown
- 2005-11-21 IT IT000239A patent/ITFI20050239A1/it unknown
-
2006
- 2006-03-07 TW TW095107569A patent/TW200724529A/zh unknown
- 2006-03-14 EA EA200701970A patent/EA012909B1/ru unknown
- 2006-03-14 AR ARP060100977A patent/AR058002A1/es not_active Application Discontinuation
- 2006-03-14 JP JP2008501287A patent/JP2008533091A/ja active Pending
- 2006-03-14 WO PCT/EP2006/060687 patent/WO2006097460A1/en active Application Filing
- 2006-03-14 CN CNA2006800066799A patent/CN101155780A/zh active Pending
- 2006-03-14 EP EP06708749A patent/EP1868997A1/en not_active Withdrawn
- 2006-03-14 MX MX2007011072A patent/MX2007011072A/es not_active Application Discontinuation
- 2006-03-14 US US11/886,160 patent/US20080207694A1/en not_active Abandoned
- 2006-03-14 KR KR1020077022763A patent/KR20070112240A/ko not_active Application Discontinuation
- 2006-03-14 AU AU2006224624A patent/AU2006224624A1/en not_active Abandoned
- 2006-03-14 BR BRPI0606290-3A patent/BRPI0606290A2/pt not_active IP Right Cessation
- 2006-03-14 AP AP2007004188A patent/AP2007004188A0/xx unknown
- 2006-03-14 CA CA002600528A patent/CA2600528A1/en not_active Abandoned
- 2006-05-08 SA SA06270135A patent/SA06270135B1/ar unknown
-
2007
- 2007-09-10 IL IL185882A patent/IL185882A0/en unknown
- 2007-10-11 MA MA30291A patent/MA29389B1/fr unknown
- 2007-10-11 CR CR9431A patent/CR9431A/es not_active Application Discontinuation
- 2007-10-12 CO CO07107399A patent/CO6321134A2/es not_active Application Discontinuation
- 2007-10-12 ZA ZA200708749A patent/ZA200708749B/xx unknown
- 2007-10-15 NO NO20075281A patent/NO20075281L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CO6321134A2 (es) | 2011-09-20 |
BRPI0606290A2 (pt) | 2009-06-09 |
US20080207694A1 (en) | 2008-08-28 |
IL185882A0 (en) | 2008-01-06 |
CN101155780A (zh) | 2008-04-02 |
ZA200708749B (en) | 2009-08-26 |
KR20070112240A (ko) | 2007-11-22 |
ITFI20050041A1 (it) | 2006-09-16 |
EP1868997A1 (en) | 2007-12-26 |
AR058002A1 (es) | 2008-01-23 |
EA012909B1 (ru) | 2010-02-26 |
NO20075281L (no) | 2007-10-15 |
WO2006097460A8 (en) | 2007-11-01 |
AP2007004188A0 (en) | 2007-10-31 |
AU2006224624A1 (en) | 2006-09-21 |
MX2007011072A (es) | 2007-10-08 |
CA2600528A1 (en) | 2006-09-21 |
JP2008533091A (ja) | 2008-08-21 |
SA06270135B1 (ar) | 2009-07-19 |
ITFI20050239A1 (it) | 2007-05-22 |
EA200701970A1 (ru) | 2008-02-28 |
TW200724529A (en) | 2007-07-01 |
MA29389B1 (fr) | 2008-04-01 |
WO2006097460A1 (en) | 2006-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CR9431A (es) | Hidroxamatos como inhibidores de la histona deacetilasa y formulaciones farmaceuticas que los contienen | |
ECSP20027480A (es) | Indolil alquil amino derivados sustituidos como nuevos inhibidores de la histona desacetilasa | |
BRPI0615690B8 (pt) | compostos heterocíclicos de hidroxamato, seus usos e composição farmacêutica | |
WO2009129335A3 (en) | Selective inhibitors of histone deacetylase | |
NI200700222A (es) | N-hydroxiamidas omega-sustituidas con grupos triciclicos como inhibidores de histona de desacetilasa, su preparación y su uso en formulaciones farmacéuticas. | |
GT200600206A (es) | Nuevos derivados del fluoreno, composiciones que los contienen y su utilizacion | |
NO20044744L (no) | Karbaminsyreforbindelser omfattende et piperazinledd som HDASinbibitorer | |
WO2007109178A3 (en) | Indole derivatives as inhibitors of histone deacetylase | |
WO2006087206A3 (en) | Androgen receptor-dependent gene expression control by inhibiting the amine oxidase activity of lysine-specific demethylase (lsd1) | |
ATE509920T1 (de) | Quadratsäurederivate als inhibitoren von histondeacetylase | |
FI7750U1 (fi) | Annostusmuoto, joka sisältää oksikodonia ja naloksonia | |
BRPI0414581A (pt) | derivados de benzimidazol: preparação e aplicações farmacêuticas | |
BRPI0613429A2 (pt) | inibidores de histona desacetilase | |
WO2010009139A3 (en) | Imidazolylpyrimidine compounds as hdac and / or cdk inhibitors | |
NO20075051L (no) | Nye sulfonylpyrroler og deres anvendelse som histon-deacetylaseinhibitorer | |
WO2004066912A3 (en) | Anti-inflammatory compositions and uses thereof | |
CL2007003000A1 (es) | Compuestos derivados de biaril eter urea; composicion farmaceutica que los contienen; y su uso para el tratamiento de enfermedades o afecciones asociadas a la actividad de amida hidrolasa de acidos grasos (faah). | |
WO2006122319A3 (en) | Histone deacetylase inhibitors | |
WO2010009155A3 (en) | Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases | |
CR9430A (es) | N-hidroxiamidas omega-sustituidas con grupos triciclos como inhibidores de histona desacetilasa, su preparacion y uso en formulaciones farmaceuticas | |
WO2011019393A3 (en) | Class- and isoform-specific hdac inhibitors and uses thereof | |
WO2010144378A3 (en) | Cycloalkylcarbamate benzamide aniline hdac inhibitor compounds | |
MA33523B1 (fr) | Microgranulés flottants | |
DK1899325T3 (da) | Imidazolinon- og hydantoinderivater som hidtil ukendte hæmmere af histondeacetylase | |
AR057162A1 (es) | Compuestos de benzamida como inhibidores de la enzima histona desacetilasa (hdac) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |